Sign inGet started

Zavodnick Todd Erik

Insider CIK 1660467 · NBY Director · ZLTQ President, International · RVNC Chief Commercial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NBY NovaBay Pharmaceuticals, I A Award deriv2019-05-302019-10-3020,000— $020,000SEC↗
RVNC Revance Therapeutics, Inc. F Tax w/h2018-10-152018-10-177,093$23.94 $169.8K96,407SEC↗
NBY NovaBay Pharmaceuticals, I A Award deriv2018-05-312018-06-0420,000— $053,698SEC↗
RVNC Revance Therapeutics, Inc. A Award deriv2018-02-082018-02-0948,750— $048,750SEC↗
RVNC Revance Therapeutics, Inc. A Award2018-02-082018-02-098,500— $0103,500SEC↗
RVNC Revance Therapeutics, Inc. A Award deriv2017-09-182017-09-2035,000— $035,000SEC↗
RVNC Revance Therapeutics, Inc. A Award2017-09-182017-09-2095,000— $095,000SEC↗
ZLTQ Zeltiq Aesthetics Inc D To issuer deriv2017-04-282017-04-2816,674— $00SEC↗
ZLTQ Zeltiq Aesthetics Inc D To issuer2017-04-282017-04-2899,971— $00SEC↗
ZLTQ Zeltiq Aesthetics Inc F Tax w/h2017-02-242017-02-287,815$55.62 $434.7K99,971SEC↗
ZLTQ Zeltiq Aesthetics Inc A Award deriv2017-01-182017-01-2016,674— $016,674SEC↗
ZLTQ Zeltiq Aesthetics Inc A Award2017-01-182017-01-208,737— $0107,786SEC↗
NBY NovaBay Pharmaceuticals, I A Award deriv2017-01-032017-01-0422,359— $033,699SEC↗
NBY NovaBay Pharmaceuticals, I A Award deriv2016-10-032016-10-043,303— $014,396SEC↗
NBY NovaBay Pharmaceuticals, I A Award deriv2016-10-032016-10-04247— $011,367SEC↗
NBY NovaBay Pharmaceuticals, I A Award deriv2016-07-012016-07-0111,093— $00SEC↗
ZLTQ Zeltiq Aesthetics Inc A Award2016-02-012016-02-0399,049— $099,049SEC↗